Assignee
TELIK INC
US·27 granted patents·7 pending applications·301 citations·filing 1997–2012
Top patents by PatentIndex Score
34 records- 0192US7262182B2Sulfonylethyl phosphorodiamidatesTELIK INC·Filed 2005·Granted Aug 28, 2007·12 cites·14 claims
- 0291US6525091B2Substituted diarylureas as stimulators for Fas-mediated apoptosisTELIK INC·Filed 2002·Granted Feb 25, 2003·36 cites·20 claims
- 0388US6506739B1Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agentsTELIK INC·Filed 2001·Granted Jan 14, 2003·26 cites·20 claims
- 0487US7029695B2Therapeutic compositions containing glutathione analogsTELIK INC·Filed 2001·Granted Apr 18, 2006·31 cites·18 claims
- 0584US6894054B2Heterocyclic inhibitors of glycine transporter 2TELIK INC·Filed 2002·Granted May 17, 2005·20 cites·2 claims
- 0683US6337338B1Heteroaryl-aryl ureas as IGF-1 receptor antagonistsTELIK INC·Filed 1999·Granted Jan 8, 2002·72 cites·22 claims
- 0782US7297696B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2004·Granted Nov 20, 2007·18 cites·33 claims
- 0881US7192918B2Tripeptide and tetrapeptide sulfonesTELIK INC·Filed 2006·Granted Mar 20, 2007·5 cites·25 claims
- 0980US6670364B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Dec 30, 2003·14 cites·65 claims
- 1077US6677365B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Jan 13, 2004·11 cites·40 claims
- 1175US6809113B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Oct 26, 2004·8 cites·40 claims
- 1273US6251689B1Methods for the solid phase synthesis of combinatorial libraries of benzimidazoles benzoxazoles benzothiazoles and derivatives thereofTELIK INC·Filed 1999·Granted Jun 26, 2001·15 cites·15 claims
- 1372US7129215B2Tripeptide and tetrapeptide thioethersTELIK INC·Filed 2006·Granted Oct 31, 2006·2 cites·24 claims
- 1469US6329431B1Nonpeptide insulin receptor agonistsTELIK INC·Filed 1997·Granted Dec 11, 2001·10 cites·25 claims
- 1568US7655799B22{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidatesTELIK INC·Filed 2006·Granted Feb 2, 2010·2 cites·18 claims
- 1667USRE38915ENonpeptide insulin receptor agonistsTELIK INC·Filed 2000·Granted Dec 6, 2005·3 cites·25 claims
- 1766US6479548B2Substituted stilbenes as glucose uptake enhancersTELIK INC·Filed 2001·Granted Nov 12, 2002·5 cites·22 claims
- 1865US7071231B2Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2002·Granted Jul 4, 2006·2 cites·20 claims
- 1964US2008159980A1Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyTELIK INC·Filed 2007·Application pending·0 cites
- 2062US6992086B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2003·Granted Jan 31, 2006·1 cites·26 claims
- 2162US6458998B1Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2000·Granted Oct 1, 2002·1 cites·37 claims
- 2257US2004138140A1Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyTELIK INC·Filed 2003·Application pending·0 cites
- 2356USRE39866ENonpeptide insulin receptor agonistsTELIK INC·Filed 2005·Granted Oct 2, 2007·0 cites·28 claims
- 2453US7872134B22-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidatesTELIK INC·Filed 2007·Granted Jan 18, 2011·0 cites·13 claims
- 2550US8361971B2Tablet formulation of ezatiostatTELIK INC·Filed 2011·Granted Jan 29, 2013·0 cites·22 claims
- 2650US2010056825A1Formulations of canfosfamide and their preparationTELIK INC·Filed 2009·Application pending·0 cites
- 2744US2013184280A1Substituted thiazoles as vegfr2 kinase inhibitorsTELIK INC·Filed 2012·Application pending·0 cites
- 2842US6528037B2Method for determining whether a compound is an insulin receptor kinase activatorTELIK INC·Filed 2002·Granted Mar 4, 2003·0 cites·5 claims
- 2942US2014315812A1Amorphous ezatiostat ansolvateTELIK INC·Filed 2012·Application pending·0 cites
- 3037US6600069B2Benzene tricarboxylic acid derivatives as insulin receptor activatorsTELIK INC·Filed 2001·Granted Jul 29, 2003·0 cites·35 claims
- 3136US6653321B1Naphthylsulfonic acids and related compounds as glucose uptake agonistsTELIK INC·Filed 2000·Granted Nov 25, 2003·0 cites·30 claims
- 3235US6054286AMethods to identify immunomodulators using cognate interaction of PKC-thetaTELIK INC·Filed 1999·Granted Apr 25, 2000·7 cites·9 claims
- 3333US2013035389A1Methods for treating myelodysplastic syndrome with ezatiostatTELIK INC·Filed 2012·Application pending·0 cites
- 3429US2008125397A12 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodiaTELIK INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TELIK INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →